Event Details

Thursday September 4, 10:57 - 11:03 AM CET
Patricio Schlottmann, MD, will be presenting the “Efficacy and Safety Outcomes over 12 weeks with OCS-01 Eye Drops in DME From DIAMOND Phase 2/3 trial: Focus on Subgroup by Lens Status”.
Session: Free Paper 1 - Diabetes & Vascular Diseases

Thursday September 4, 11:03 - 11:09 AM CET
Veeral Sheth, MD, MBA, FACS, FASRS, will be presenting the “Efficacy and Safety Outcomes over 12 weeks with OCS-01 Eye Drops in DME From DIAMOND-Stage 1 trial: Focus on Subgroup by Prior Treatment Status”.
Session: Free Paper 1 - Diabetes & Vascular Diseases

Friday September 5, 3:57 - 4:03 PM CET
Sophie Bonnin, MD, will be presenting the “Improved Low Contrast Visual Acuity and Reduction in Retinal Ganglion Cell Loss with Privosegtor in Acute Optic Neuritis: Results from a Multicenter Randomized Placebo-Controlled Double-Masked Trial”.
Session: Euretina Session 7 - First Time Clinical Trials & Late Breaking Session